Now, the growing buzz around the use of GLP-1 medications like Ozempic to treat alcohol use disorder finally has new clinical ...

This is just a tiny glimpse of the data available to CivicScience clients. Discover more data. CivicScience has data on over ...

Learn about the financial strain caused by the skyrocketing demand and costs of GLP-1 drugs, and how health plans and providers are struggling to balance it.

A majority with overweight/obesity discontinue within a year, but the rate is higher among those without type 2 diabetes.

Novo Nordisk's sales and profits were both up around 30% last quarter. Its GLP-1 weight loss drug has been a driving force ...

They're known to aid in blood sugar control and, now, weight loss — however, according to a sweeping new study, the popular ...

Ryals McMullian noted consumers are moving away from traditional white and wheat bread into organic, keto, gluten-free and ...

Obesity medication prescriptions reached 1.5 million, driven by GLP-1 agents semaglutide and tirzepatide, as public interest ...

According to the journal JAMA Health Forum, prescription fills for Ozempic increased by more than 400% between January 2021 ...

However, the rising popularity of GLP-1 drugs, which are highly effective in helping people lose weight and also reduce the ...

Groundbreaking research reveals how common diabetes medications might offer unprecedented protection against heart attacks ...